Related Experiment Videos
Phase I study of escalating does of carboplatin
Cancer Chemotherapy and Pharmacology
|January 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
Clinical pharmacology and therapeutics·2017
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: Outcomes and Metrics of Pharmacogenetic Implementations Across Diverse Healthcare Systems.
Clinical pharmacology and therapeutics·2017
Food Effect Studies for Oncology Drug Products.
Clinical pharmacology and therapeutics·2017
Patient Perceptions of Care as Influenced by a Large Institutional Pharmacogenomic Implementation Program.
Clinical pharmacology and therapeutics·2016
ABC transporter polymorphisms are associated with irinotecan pharmacokinetics and neutropenia.
The pharmacogenomics journal·2016
Intensification versus combination: revisiting the past and envisioning the future of LDHA inhibitors.
Cancer chemotherapy and pharmacology·2026
Circulatory compromise as a potential mechanism of fatal hepatic failure during long-term selpercatinib therapy: pharmacokinetic and clinical insights.
Cancer chemotherapy and pharmacology·2026
CDCP1-targeted antibody-drug conjugates and immunocytokines for cancer therapy.
Cancer chemotherapy and pharmacology·2026
Pharmacokinetic and pharmacodynamic sub-study of trans-arterial vs. intravenous gemcitabine in the TIGeR-PaC phase 3 clinical trial.
Cancer chemotherapy and pharmacology·2026
A phase 1, open-label study evaluating the pharmacokinetics, safety, and tolerability of vepdegestrant in Chinese patients with ER+/HER2- advanced breast cancer.
Cancer chemotherapy and pharmacology·2026
Quantitative characterization of platelet count and alanine aminotransferase dynamics to inform personalized dosing in the first-in-human LP-184 trial.
Cancer chemotherapy and pharmacology·2026
Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy.
Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Elacestrant in Combination with Everolimus for Estrogen Receptor-Positive, HER2-Negative Previously Treated Advanced Breast Cancer: Results from ELEVATE.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Association between ineffective health self-management and severe radiodermatitis: Cohort study.
International journal of nursing knowledge·2026
Systematic review: Stereotactic Body Radiation Therapy for Pancreatic Cancer: Evaluating its Efficacy, Safety, and Future Prospects.
The British journal of radiology·2026
A prospective, randomized study comparing different therapeutic modalities for acute adenoviral conjunctivitis.
Indian journal of ophthalmology·2026